首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
phaeohyphomycosis相关文献:
Phaeohyphomycosis.
Arcobello JT, Revankar SG.
Semin Respir Crit Care Med. 2020 Feb;41(1):131-140. doi: 10.1055/s-0039-3400957. Epub 2020 Jan 30.
PMID:32000289
Phaeohyphomycosis in China.
He Y, Zheng HL, Mei H, Lv GX, Liu WD, Li XF.
Front Cell Infect Microbiol. 2022 Jun 13;12:895329. doi: 10.3389/fcimb.2022.895329. eCollection 2022.
PMID:35770068
Phaeohyphomycosis.
Revankar SG.
Infect Dis Clin North Am. 2006 Sep;20(3):609-20. doi: 10.1016/j.idc.2006.06.004.
PMID:16984871
Pediatric Phaeohyphomycosis: A 44-Year Systematic Review of Reported Cases.
Bejarano JIC, de Los Santos AM, Cisneros Saldaña D, Zambrano Lucio M, Pérez Cavazos S, Espinosa Villaseñor F, de la O Cavazos ME, Aparicio DNV.
J Pediatric Infect Dis Soc. 2023 Feb 9;12(1):10-20. doi: 10.1093/jpids/piac106.
PMID:36170027
Emerging Cutaneous Phaeohyphomycosis Caused by Alternaria infectoria.
Kieselová K, Gomes T, Santiago F, Martinha H.
Acta Med Port. 2021 Nov 2;34(11):774-778. doi: 10.20344/amp.13496. Epub 2020 Oct 12.
PMID:33054931
Phaeohyphomycosis in Transplant Patients.
Revankar SG.
J Fungi (Basel). 2015 Dec 22;2(1):2. doi: 10.3390/jof2010002.
PMID:29376919
Mouse Models of Phaeohyphomycosis.
Zhang Y, Li R.
Methods Mol Biol. 2023;2667:159-168. doi: 10.1007/978-1-0716-3199-7_12.
PMID:37145283
Phaeohyphomycosis caused by Phialophora americana with CARD9 mutation and 20-year literature review in China.
Huang C, Zhang Y, Song Y, Wan Z, Wang X, Li R.
Mycoses. 2019 Oct;62(10):908-919. doi: 10.1111/myc.12962. Epub 2019 Jul 23.
PMID:31271673
Phaeohyphomycosis Due to Verruconis gallopava: Rare Indolent Pulmonary Infection or Severe Cerebral Fungal Disease?
Terracol L, Hamane S, Euzen V, Denis B, Bretagne S, Dellière S.
Mycopathologia. 2024 Nov 20;189(6):99. doi: 10.1007/s11046-024-00903-9.
PMID:39565406
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis.
Drummond RA, Desai JV, Hsu AP, Oikonomou V, Vinh DC, Acklin JA, Abers MS, Walkiewicz MA, Anzick SL, Swamydas M, Vautier S, Natarajan M, Oler AJ, Yamanaka D, Mayer-Barber KD, Iwakura Y, Bianchi D, Driscoll B, Hauck K, Kline A, Viall NS, Zerbe CS, Ferré EM, Schmitt MM, DiMaggio T, Pittaluga S, Butman JA, Zelazny AM, Shea YR, Arias CA, Ashbaugh C, Mahmood M, Temesgen Z, Theofiles AG, Nigo M, Moudgal V, Bloch KC, Kelly SG, Whitworth MS, Rao G, Whitener CJ, Mafi N, Gea-Banacloche J, Kenyon LC, Miller WR, Boggian K, Gilbert A, Sincock M, Freeman AF, Bennett JE, Hasbun R, Mikelis CM, Kwon-Chung KJ, Belkaid Y, Brown GD, Lim JK, Kuhns DB, Holland SM, Lionakis MS.
J Clin Invest. 2022 Nov 15;132(22):e159348. doi: 10.1172/JCI159348.
PMID:36377664
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3